Asymchem

Activities: Manufacturing Regulatory

Since inception in 1999, Asymchem has been positioned and structured to act as a true partner for pharmaceutical and biotech companies by offering integrated solutions across all stages of drug development and into commercialisation.

Trending Articles

  1. BioreclamationIVT supports drug, diagnostic and vaccine research for infectious diseases BioreclamationIVT will now offers HIV-1, HIV-2, dengue, zika and malaria blood-derived biological samples to advance drug, diagnostic and vaccine development against these...
  2. WHO pandemic agreement determined after three years of negotiation Through the deal, WHO will promote a unified, global response to future pandemics, ensuring that national health systems are equipped to control future outbreaks
  3. Partnering for success: adaptable CDMO solutions for pharma, diagnostics, and biotech When it comes to liquid formulations and freeze-drying (lyophilisation) services, choosing a contract development and manufacturing organisation (CDMO) that prioritises...
  4. Capricorn Scientific and florabio join forces to supply animal-free vaccine solutions Strategic partnership will accelerate innovation from lab to GMP scale with high-yield solutions for scalable production
  5. RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...

Upcoming event

Making Pharmaceuticals

29-30 April 2025 | Conference | Coventry, UK See all

Related Content

Manufacturing

Asymchem fully automates its therapeutic peptide manufacturing processes

The company has facilitated the scale-up of its peptide manufacturing capabilities, with its production capacity now standing at 10,000 L
Research & Development

Asymchem develops AI platform to optimise protein design in drug development

Sequence Recommendation via Artificial Intelligence (STAR) addresses key challenges in protein design through intelligent algorithms and data-driven insights
Manufacturing

Asymchem extends its commitment to developing advanced manufacturing technologies

The company has invested significantly into bolstering its supply chain, while also creating advanced manufacturing technologies
Manufacturing

Asymchem inaugurates its UK small molecule development and API pilot plant manufacturing site

The site will focus on the manufacture of peptides and oligonucleotides, while also housing a number of R&D labs
Manufacturing

Asymchem appoints Dr Cheng Yi Chen as CTO of Small Molecules

He will support the group's small molecule sales and offer technical guidance to laboratories and pilot production sites across Europe
Manufacturing

Asymchem hires Franck Mevellec as Senior Director of business development

Franck has more than 20 years of industry experience, holding key positions in sales, R&D and portfolio management
Manufacturing

Asymchem acquires former Pfizer development and API pilot plant manufacturing facilities at Discovery Park

The acquisition will expand Asymchem's global reach to the UK, as well as giving the company access to development laboratories and an API pilot plant
Subscribe now